Figure 6

100Â ns MD simulation trajectory representing the RMSD assessment, ligand-receptor interaction profile and ligand-receptor interaction timeline for LasR-ODDHL, LasR-6-Gingerol, and LasR-Curcumin complexes.
100Â ns MD simulation trajectory representing the RMSD assessment, ligand-receptor interaction profile and ligand-receptor interaction timeline for LasR-ODDHL, LasR-6-Gingerol, and LasR-Curcumin complexes.